Biomarker qualification for drug-induced liver injury across species using immunoaffinity mass spectrometry
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
Tübingen, Universität Tübingen, Dissertation, 2022
- Keyword
-
Biomarker
- Event
-
Veröffentlichung
- (where)
-
Tübingen
- (who)
-
Universitätsbibliothek Tübingen
- (when)
-
2024
- Creator
-
Anselm, Viktoria
- Contributor
-
Stehle, Thilo
- URN
-
urn:nbn:de:bsz:21-dspace-1262950
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:48 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Anselm, Viktoria
- Stehle, Thilo
- Universitätsbibliothek Tübingen
Time of origin
- 2024
Other Objects (12)
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Ginseng-Related Drug-Induced Liver Injury
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
Drug-induced mitochondrial impairment in liver cells
The challenge of drug-induced liver injury (DILI)
A brief overview of drug-induced liver damage
Drug-Induced Liver Injury (DILI): A Major Challenge
Predictability of drug-induced liver injury by machine learning
Lorazepam as a Cause of Drug-Induced Liver Injury
A Patient with Nafcillin-Associated Drug-Induced Liver Failure
Biomarker Assay Validation by Mass Spectrometry
Drug-induced liver injury due to varenicline: a case report
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Ginseng-Related Drug-Induced Liver Injury
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
Drug-induced mitochondrial impairment in liver cells
The challenge of drug-induced liver injury (DILI)
A brief overview of drug-induced liver damage
Drug-Induced Liver Injury (DILI): A Major Challenge
Predictability of drug-induced liver injury by machine learning
Lorazepam as a Cause of Drug-Induced Liver Injury
A Patient with Nafcillin-Associated Drug-Induced Liver Failure
Biomarker Assay Validation by Mass Spectrometry
Drug-induced liver injury due to varenicline: a case report
The application of cytokeratin-18 as a biomarker for drug-induced liver injury
Ginseng-Related Drug-Induced Liver Injury
Drug-Induced Liver Injury from Herbal Liver Detoxification Tea
Drug-induced mitochondrial impairment in liver cells
The challenge of drug-induced liver injury (DILI)
A brief overview of drug-induced liver damage
Drug-Induced Liver Injury (DILI): A Major Challenge
Predictability of drug-induced liver injury by machine learning
Lorazepam as a Cause of Drug-Induced Liver Injury
A Patient with Nafcillin-Associated Drug-Induced Liver Failure
Biomarker Assay Validation by Mass Spectrometry